[ad_1]
NEW YORK (Reuters Health) – A daily anti-baldness drug from US President Donald Trump could help millions of men around the world protect them from serious diseases, according to a new study.
The study, which lasted about 20 years, indicates that the drug "Finasteride", which treats hair loss, also contributes to the fight against prostate cancer, according to the British newspaper "Daily Mail".
In the United States and Britain, men use this medicine to keep their hair off.
Researchers at the University of Texas at the University of Texas have stated that men at risk for prostate cancer, who appears on the blood test for the disease known as PSA, prefer to give them medicines that reduce the risk of developing the disease.
Ian Thompson, co-author of the study, said that more than 19,000 cases of men had been followed since 1997, pointing out that finasteride was safe, inexpensive, and effective in preventing the disease, highlighting the need for physicians to share these results with their patients (PSA).
The drug works against enlargement of the prostate, which poses the problem of frequent urination of men during the night, but it has not yet been approved in the United States as a drug to treat the prostate, after a previous study published several years ago, which aggravates the disease.
On the other hand, the British experts received very carefully the results of the study, believing that the drug fought non-serious tumors that could not kill men, noting that the chances of prostate cancer decreased considerably, but that did not mean not the end of the chances of death.
[ad_2]
Source link
